Framework for Bias Detection in Synthetic Health Data

1. Introduction

Synthetic health data refers to artificially generated medical information that reproduces the statistical characteristics of real patient data without necessarily representing actual individuals. It is used in medical research, artificial intelligence (AI) development, clinical trials, disease prediction, and healthcare innovation. Although synthetic data can improve privacy and facilitate research, it may reproduce or amplify biases present in the original datasets.

Bias detection in synthetic health data is the systematic process of identifying and correcting unfair differences in data generation, representation, and predictive performance across demographic groups. These groups may be defined by gender, age, ethnicity, disability, socioeconomic status, or geographical location. An effective framework must ensure fairness, privacy, scientific validity, and equal access to healthcare benefits.

2. Legal and Regulatory Framework

An effective bias detection framework should incorporate the following elements:

A. Dataset Assessment: The original dataset must be examined for underrepresentation, missing information, historical discrimination, and unequal access to healthcare. For example, if a dataset contains fewer records from rural patients, synthetic generation may reproduce this imbalance.

B. Demographic Representation: Synthetic datasets should be evaluated to determine whether relevant patient groups are adequately represented. Researchers should compare the distribution of age, gender, disease severity, and other clinically relevant variables between real and synthetic datasets.

C. Statistical and Clinical Validation: Statistical similarity alone does not establish fairness. Researchers must test whether synthetic data preserves disease prevalence, treatment outcomes, diagnostic accuracy, and clinically significant relationships across different populations.

D. Fairness Auditing: Models trained on synthetic data should be tested separately across demographic groups. Measures may include false-positive rates, false-negative rates, sensitivity, specificity, and calibration. Differences should be investigated to determine whether they result from sampling errors, biased source data, or inappropriate model design.

E. Independent Review: Healthcare institutions should maintain audit records, document limitations, and arrange independent assessment before using synthetic datasets in consequential clinical applications.

3. Major Methods for Detecting Bias

The framework should use a combination of quantitative and qualitative methods.

Representation analysis: Compare the demographic distribution of real and synthetic datasets.

Subgroup performance testing: Evaluate whether diagnostic or predictive models perform differently across patient groups.

Intersectional analysis: Examine overlapping characteristics, such as older women from rural communities, because aggregate statistics may conceal disadvantages affecting smaller groups.

Counterfactual testing: Assess whether changing a sensitive attribute while holding clinically relevant factors constant changes a model's prediction in an unjustified manner.

External validation: Test synthetic-data-trained models on independent real-world patient datasets.

Continuous monitoring: Reassess bias when datasets, generation methods, clinical populations, or model applications change.

Importantly, demographic parity is not always the appropriate standard in healthcare. Differences in disease prevalence or clinical need may be medically relevant. Fairness assessments must therefore consider clinical context, rather than treating every statistical difference as unlawful discrimination.

4. Important Case Laws

A. State of Punjab v. Davinder Singh (2024)

The Supreme Court of India recognised that treating all members of a broad social category as homogeneous can conceal internal inequalities and accepted the constitutional permissibility of evidence-based sub-classification within Scheduled Castes.

Relevance: Although the case did not concern synthetic health data, its reasoning illustrates why aggregate statistics may conceal disadvantages experienced by particular subgroups. Bias audits should therefore examine intersectional and subgroup differences rather than relying exclusively on overall dataset accuracy.

B. National Legal Services Authority v. Union of India (2014)

The Supreme Court of India recognised the rights and dignity of transgender persons and affirmed constitutional protections against discrimination.

Relevance: Healthcare datasets should not exclude or misclassify transgender and gender-diverse patients. Synthetic data generation should preserve appropriate demographic representation and avoid reinforcing stereotypes or discriminatory treatment.

C. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

The Supreme Court recognised privacy as a fundamental right under Article 21 of the Indian Constitution, including informational privacy and the importance of individual autonomy.

Relevance: Synthetic health data must be assessed not only for fairness but also for privacy risks. A dataset may reproduce demographic bias or disclose sensitive information through memorisation and re-identification. Privacy-preserving generation, access controls, and disclosure-risk testing are therefore essential.

D. Griggs v. Duke Power Co. (1971)

The United States Supreme Court held that employment practices that appear neutral may violate anti-discrimination law when they disproportionately disadvantage protected groups and lack adequate justification.

Relevance: The case provides a useful comparative principle for algorithmic fairness: apparently neutral data-generation rules can produce discriminatory outcomes. However, its legal holding concerned employment discrimination, not healthcare AI.

E. Obermeyer et al., Science (2019)

In Dissecting racial bias in an algorithm used to manage the health of populations, researchers demonstrated that a widely used healthcare algorithm underestimated the health needs of Black patients because healthcare costs were used as a proxy for illness.

Relevance: Although this was a research study rather than a court judgment, it is directly relevant to synthetic health data. If synthetic datasets reproduce biased proxies from historical healthcare systems, models trained on them may perpetuate unequal allocation of medical resources.

5. Implementation and Accountability

Healthcare organisations should establish a documented process involving dataset inventory, demographic assessment, bias testing, independent validation, corrective action, and periodic reassessment. Data scientists should record the synthetic data generator, source-data limitations, evaluation metrics, and known subgroup weaknesses.

Where significant bias is detected, the organisation should revise the generation process, improve underrepresented-group sampling where scientifically justified, reconsider biased proxy variables, and repeat validation using independent clinical data. Synthetic data should not be treated as automatically anonymous, unbiased, or clinically reliable.

In India, relevant legal considerations include the Constitution's equality guarantees under Articles 14 and 15, applicable provisions of the Digital Personal Data Protection Act, 2023, and other applicable healthcare, research, and data-protection requirements. Their precise application depends on the institution, purpose, data involved, and provisions in force.

6. Conclusion

The framework for bias detection in synthetic health data must integrate statistical testing, subgroup fairness analysis, clinical validation, privacy safeguards, legal compliance, and independent accountability. The central principle is that synthetic data is only as trustworthy as the methods used to generate, validate, and govern it. By detecting hidden inequalities before deployment, healthcare institutions can develop AI systems that are more reliable, inclusive, and consistent with human dignity and equality.